THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Bristol Myers Squibb and Sarah Cannon expand strategic oncology research collaboration
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Bristol Myers Squibb and Sarah Cannon Research Institute expanded a strategic collaboration using SCRI’s Accelero clinical-trial delivery model to accelerate patient enrollment and broaden access to oncology trials.
- Current status
- Official collaboration
- Known availability
- Started 2025-11-12; the official source does not state an end date.
- Place
- Nashville, United States
- Source checked
- September 13, 2026
FOLLOW THE STORY